These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26349733)

  • 1. [Metabolic syndrome and hypogonadism. Testosteron may protect the heart in type 2 diabetes mellitus].
    Schaaf L
    MMW Fortschr Med; 2015 Sep; 157(15):65-7. PubMed ID: 26349733
    [No Abstract]   [Full Text] [Related]  

  • 2. [Testosterone deficiency, metabolic syndrome and diabetes mellitus].
    Fernández-Miró M; Chillarón JJ; Pedro-Botet J
    Med Clin (Barc); 2016 Jan; 146(2):69-73. PubMed ID: 26433309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Overview of Testosterone Therapy.
    Lee OD; Tillman K
    Am J Mens Health; 2016 Jan; 10(1):68-72. PubMed ID: 25398416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction.
    Guay AT; Traish A
    Urol Clin North Am; 2011 May; 38(2):175-83. PubMed ID: 21621084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and hypogonadism--two peas in a pod.
    Ebrahimi F; Christ-Crain M
    Swiss Med Wkly; 2016; 146():w14283. PubMed ID: 26999489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Testosterone supplementary therapy for type-2 diabetes mellitus males with hypogonadism: Controversy and analysis].
    Cheng Z; Zhang LY; Chen GM; He W; Cai K; Liao ZH
    Zhonghua Nan Ke Xue; 2017 Aug; 23(8):739-744. PubMed ID: 29726651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sexual dysfunction in male: a matter of old age or a warning signal?].
    Stadler TC; Stief CG; Becker AJ
    MMW Fortschr Med; 2009 Apr; 151(14):72-4, 76; quiz 78. PubMed ID: 19504845
    [No Abstract]   [Full Text] [Related]  

  • 8. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
    Mäkinen JI; Huhtaniemi I
    Gerontology; 2011; 57(3):193-202. PubMed ID: 20689266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYTHS AND CONTROVERSIES IN HYPOGONADISM TREATMENT OF AGING MALES.
    Ungureanu MC; Costache II; Preda C; Mogoş V; Vulpoi C; Leuştean L
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):325-33. PubMed ID: 26204632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving issues in male hypogonadism: evaluation, management, and related comorbidities.
    Miner MM; Sadovsky R
    Cleve Clin J Med; 2007 May; 74 Suppl 3():S38-46. PubMed ID: 17549824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes.
    Corona G; Rastrelli G; Maggi M
    Best Pract Res Clin Endocrinol Metab; 2013 Aug; 27(4):557-79. PubMed ID: 24054931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism.
    La Vignera S; Calogero AE; D'Agata R; Di Mauro M; Tumino S; Condorelli R; Lanzafame F; Finocchiaro C; Giammusso B; Vicari E
    Minerva Endocrinol; 2008 Sep; 33(3):159-67. PubMed ID: 18846023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone deficiency.
    Traish AM; Miner MM; Morgentaler A; Zitzmann M
    Am J Med; 2011 Jul; 124(7):578-87. PubMed ID: 21683825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone and mortality.
    Muraleedharan V; Jones TH
    Clin Endocrinol (Oxf); 2014 Oct; 81(4):477-87. PubMed ID: 25041142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging link between hypogonadism and metabolic syndrome.
    Guay AT
    J Androl; 2009; 30(4):370-6. PubMed ID: 18772486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypogonadism and metabolic syndrome: implications for testosterone therapy.
    Makhsida N; Shah J; Yan G; Fisch H; Shabsigh R
    J Urol; 2005 Sep; 174(3):827-34. PubMed ID: 16093964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
    Miner MM; Seftel AD
    Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAVERSING the Mountain of Ignorance: Testosterone and Cardiovascular Safety.
    Anawalt BD
    J Clin Endocrinol Metab; 2024 Mar; 109(4):e1359-e1360. PubMed ID: 37738547
    [No Abstract]   [Full Text] [Related]  

  • 19. Testosterone replacement in men.
    Beg S; Al-Khoury L; Cunningham GR
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Male hypogonadism: pathogenesis, diagnosis, and management.
    De Silva NL; Papanikolaou N; Grossmann M; Antonio L; Quinton R; Anawalt BD; Jayasena CN
    Lancet Diabetes Endocrinol; 2024 Oct; 12(10):761-774. PubMed ID: 39159641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.